Related Experiment Videos
Clinical aspects of primary vasculitis
1Department of Internal Medicine/Division of Nephrology, University Hospital Groningen, Faculty of Medical Sciences, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. C.A.Stegeman@int.azg.nl
Springer Seminars in Immunopathology
|October 10, 2001
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Nasal Microbiome in ANCA-Associated Vasculitis: Picking the Nose for Clues on Disease Pathogenesis.
Current rheumatology reports·2021
Influence of gender on the performance of urine dipstick and automated urinalysis in the diagnosis of urinary tract infections at the emergency department.
European journal of internal medicine·2021
Routine tests and automated urinalysis in patients with suspected urinary tract infection at the ED.
The American journal of emergency medicine·2016
Pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis and potential targets for biologic treatment.
Nephron. Clinical practice·2014
Accurate and fast diagnostic algorithm for febrile urinary tract infections in humans.
The Netherlands journal of medicine·2014
Characterization of urinary CD4⁺ and CD8⁺ T cells in kidney transplantation patients with polyomavirus BK infection and allograft rejection.
Transplant infectious disease : an official journal of the Transplantation Society·2014
Activating and inhibitory FcgammaRs in autoimmune disorders.
Springer seminars in immunopathology·2006
Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy.
Springer seminars in immunopathology·2006
Fcepsilon- and Fcgamma-receptor signaling in diseases.
Springer seminars in immunopathology·2006
Fc gamma receptors and cancer.
Springer seminars in immunopathology·2006
FcgammaRII and multi-system autoimmune disease.
Springer seminars in immunopathology·2006
Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity.
Springer seminars in immunopathology·2006
Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Outcomes in Three Patients.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Giant cell arteritis during risankizumab therapy: a possible paradoxical reaction to IL-23 inhibition.
Immunological medicine·2026
Small Intestinal Extranodal Marginal Zone Lymphoma Mimicking Crohn's Disease.
ACG case reports journal·2026